Skip to main content
Sign In

Residency News

03/17/19 - Pink Vail Wellness Day

Residents, staff and department chair Dr. Brian Kavanagh took to the slopes at the Pink Vail day on March 17th. 

The fundraiser supported breast cancer awareness in partnership with the Vail Valley Medical Center.

09/24/18 - Mueller receives research grant

PGY-4 resident Adam Mueller was recently selected as the 2018-2019 Paul Sandoval Pancreatic Cancer Scholar. Based on his application and credentials the Sandoval scholarship committee determined his project had great potential for improved therapeutic options for pancreas cancer patients, in the spirit of the scholarship established by the Sandoval family in memory of Paul Sandoval who succumbed to pancreas cancer in 2014. This scholarship provides $20,000 funding for one year, with a potential for a second year of funding. He plans to spend that year researching molecular fingerprints of therapeutic resistance in pancreatic cancer tumor samples from patients treated with neoadjuvant SBRT, in the laboratory of Radiation Oncology faculty member Dr. Sana Karam.

4/24/18: Dr. Jain selected for a 2018 ACR Annual Meeting Travel Grant

Supriya-ResidencyPhoto.jpgSupriya Jain, MD, MHS has been awarded one of this year’s American College of Radiology Resident Travel Grants by CARROS (Council of Affiliated Regional Radiation Oncology Societies). Each year, CARROS provides two scholarships to help fund resident attendance at ACR's Annual Meeting. She will be attending the annual meeting in Washington D.C. this May. The meeting provides a broad forum to discuss and explore critical topics in economics, health policy and advocacy. In addition to these sessions, Supriya will attend the CARROS meeting and caucus and meet with members of Congress during the ACR’s Capitol Hill Day.


4/19/18 - Is whole-brain radiation still required for all brain metastases from small-cell lung cancer?​​
recent study from Dr. Rusthoven and Dr. Robin challenges the use of whole-brain radiation for all small-cell lung cancer patients with brain metastases. The study, recently published in the journal Lung Cancer, compared the outcomes of 5,752 small-cell lung cancer patients who received whole-brain radiation therapy (WBRT) with those of 200 patients who received stereotactic radiosurgery (SRS), finding that the median overall survival was actually longer with SRS (10.8 months with SRS versus 7.1 months with WBRT). Read the full article here
4/16/18: Department of Radiation Oncology Residents Recognized by Gold Humanism Honor Society
Dr. David Binder, PGY-3, and Dr. Adam Mueller, PGY-3, were inducted to the resident and fellows chapter of the Gold Humanism Honor Society.
12/19/17 - Robin & Rusthoven report remarkable radiosurgery results
Drs. Tyler Robin, PGY-4 resident in radiation oncology, and Chad Rusthoven, Assistant Professor of Radiation Oncology, have published a paper in the Journal of Thoracic Oncology demonstrating excellent survivorship in patients with four or more brain metastases from EGFR-mutated and ALK-rearranged lung cancer treated with radiosurgery alone. A median survival of 3.0 years (4.2 for ALK, 2.4 for EGFR) from the diagnosis of brain metastases was achieved, and survival was equivalent regardless of number of radiosurgery courses, number of tumors treated in total, or number of tumors treated in a single radiosurgery session. 


“It used to be that once lung cancer metastasized to the brain, the prognosis was
poor. Whole brain radiation therapy decreases the risk of death from neurologic causes, but at a steep cost. This study suggests that for lung cancer patients on targeted therapies whose cancer has spread to the brain, the use of radiosurgery makes it rare to die of causes related to brain metastases,” says Tyler Robin, MD, PhD, the paper’s first author. Robin also measured dose to non-target structures such as the hippocampus and demonstrated that radiosurgery yielded substantially lower dose to this and other parts of normal brain than even the most sophisticated techniques of whole brain radiotherapy.  Adds senior author Dr. Rusthoven, “The very low dose of radiation to the normal brain observed with radiosurgery compared to whole-brain radiation has the potential to dramatically lower the risk of cognitive side effects.”

0/27/17: Robin and Fisher Open Investigator Initiated Trial for Patients with Ovarian and Uterine Cancer

Dr. Tyler Robin, PGY-4, and his mentor, Dr. Christine Fisher, Associate Professor of Radiation Oncology, opened their phase I clinical trial utilizing stereotactic body radiation therapy (SBRT) for patients with limited locoregional recurrences of ovarian and uterine serous carcinoma. They received funding and support from the Cancer Center for this effort. They are collaborating with Dr. Bernard Jones in our Division of Medical Physics to learn more about the functional imaging correlates of SBRT, and with the Human Immune Monitoring Shared Resource (HIMSR) in the School of Medicine for analysis of novel biologic endpoints. Dr. Robin and Dr. Fisher are excited to be able to offer this clinical trial as a treatment option for our patients.


09/22/17: Residents Head to ASTRO to Present New Research​

Current residents, Dr. Tyler Robin, PGY-4, Dr. William Stokes, PGY-5, and Dr. Priscilla Stumpf, PGY-5, will be presenting new research at the 2017 ASTRO Annual Meeting in San Diego, CA. Dr. Robin will be giving an ePoster presentation entitled “Fiducial Markers are Necessary for Accurate Delivery of Liver SBRT”. Dr. Stokes will also be giving an ePoster presentation on “Treatment-Related Mortality Among Early-Stage NSCLC Patients Undergoing Surgery versus SBRT”. Dr. Stumpf will be presenting a poster on “Patterns of Care in the US Regarding Utilization of Postoperative Radiation In Low Grade Gliomas”. Additionally, former resident, Dr. Arya Amini, now Assistant Professor of Radiation Oncology at the City of Hope National Medical Center, was invited to give an oral presentation on work he completed during his residency on “Rising Rates of Upfront Surgery Followed By Radiation in Locally Advanced Cervical Cancer”.


08/04/17: Jain Accepted to Prestigious Clinical Trials Course

Supriya-ResidencyPhoto.jpgDr. Supriya Jain, PGY-4, returns from the 2017 ASCO/AACR Workshop on Methods in Clinical Cancer Research in Vail, CO. She is working on the design and implementation of a clinical protocol under the faculty mentorship of Dr. Karyn Goodman, entitled “Phase I Study of Dual Immune Checkpoint Blockade (Anti-PD-L1 (Durvalumab) and Anti-CTLA4 (Tremelimumab)) Plus Yttrium-90 (Y-90) Radioembolization & Stereotactic Body Radiation Therapy (SBRT) in Refractory Metastatic MSS (Microsatellite Stable) Colorectal Cancer with Liver Metastases”. She continued development of this exciting protocol at this year’s intensive workshop.


07/15/17: Robin Joins Global Health Team

In 2010, Dr. Patricia Hardenbergh from the Shaw Cancer Center in Edwards, CO, founded, a web-based platform to connect community based radiation oncologists with disease-site experts for real time peer review and case discussion. Building on the success of in the US, Dr. Hardenbergh is now expanding the global reach of Chartrounds. will launch individual sites for different global regions, and Dr. Hardenbergh has recruited Dr. Tyler Robin, PGY-4, to lead the Chartrounds India initiative. Check out what’s new with Chartrounds India at


05/02/17: Stokes Receives Travel Grant for ASTRO Advocacy Day

Dr. William Stokes, PGY, 4, attends ASTRO advocacy day with Dr. Brian Kavanagh, Professor and Chair of the Department of Radiation Oncology. Dr. Stokes’ received a travel grant for his trip to Capital Hill.


4/26/17: University of Colorado Radiation Oncology Residents Recognized by Gold Humanism Honor Society

Dr. Supriya Jain, PGY-3, and Dr. Tyler Robin, PGY-3, were inducted into the resident and fellows chapter of the Gold Humanism Honor Society.


04/20/17: Stokes Gives Oral Presentation at American Brachytherapy Society

​Dr. William Stokes, PGY-4, was selected to give an oral presentation at the 2017 American Brachytherapy Society Annual Meeting. The title of his talk is “Brachytherapy should not be Omitted from the Adjuvant Management of Uterine Carcinosarcoma”.

2/15/17 - Robin’s Research Cited in New York Times Article on Disparities
A recent publication authored by Dr. Tyler Robin, PGY-3, Department of Radiation Oncology, has received national attention. The article, “Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer”, was cited in a New York Times article addressing disparities in cervical cancer treatment. 
Senior author Dr. Christine Fisher commented, “Dr. Robin's study revealed a very important and concerning point. Fewer than half of patients with locally advanced cervix cancer receive appropriate standard therapy for their cancer, which should include both external beam radiotherapy and brachytherapy. Patients were more likely to receive substandard therapy if they had lower incomes, only Medicaid insurance, or treatment outside of a comprehensive cancer center. We hope that by illuminating the problem we can educate patients and providers outside of major centers that referral to a comprehensive cancer center like ours is important if the appropriate expertise and technology for proper treatment is unavailable locally. Cervix cancer can be challenging to treat but is potentially curable, and it is important that the oncology community rallies to the support of the vulnerable populations of patients who need access to standard care.  Our ultimate hope is for elimination of cervical cancer through vaccination and screening, but, until then, access to best care is critically important for cervix cancer patients. 
Co-authors of the study included Dr. Arya Amini, PGY-5, Department of Radiation Oncology; Dr. Tracey Schefter, Department of Radiation Oncology; and Dr. Kian Behbahkt, Director of Gynecologic Oncology.

Click here to see Recent Resident Publications​